1. < Home

overweight

GLP-1 Receptor Agonists Among Patients With Overweight or Obesity, Diabetes, and HFpEF on SGLT2 Inhibitors

Patel R, Wadid M, Makwana B, Kumar A, Khadke S, Bhatti A, Banker A, Husami Z, Labib S, Venesy D, Fonarow G, Kosiborod M, Al-Kindi[...]

By sjmartinez • September 1, 2024
Automated abdominal adipose tissue segmentation and volume quantification on longitudinal MRI using 3D convolutional neural networks with multi-contrast inputs

Kafali SG, Shih SF, Li X, Kim GHJ, Kelly T, Chowdhury S, Loong S, Moretz J, Barnes SR, Li Z, Wu HH. Automated abdominal adipose[...]

By sjmartinez • February 2, 2024
Eligibility for Cardiovascular Risk Reduction Therapy in the United States Based on SELECT Trial Criteria: Insights From the National Health and Nutrition Examination Survey

Lu Y, Liu Y, Jastreboff AM, Khera R, Ndumele CD, Rodriguez F, Watson KE, Krumholz HM. Eligibility for Cardiovascular Risk Reduction Therapy in the United[...]

By sjmartinez • January 17, 2024